Hypoglycemia

People with well-managed diabetes who wish to try intermittent fasting for weight loss or other reasons can do so safely with careful attention to glucose levels, particularly with continuous glucose monitoring, according to two speakers.

People with diabetes reported identifying and treating “low” and “hypo” at relatively high blood glucose levels, and that symptoms of hypoglycemia changed over time, according to survey results.

Children with type 1 diabetes who received continued psychological care had a decrease in severe hypoglycemic episodes and stable glycemic control during 2 years of follow up, according to a study published in Pediatric Diabetes.

Results of a prospective, observational study showed that patients with chronic kidney disease and type 2 diabetes experienced frequent hypoglycemic episodes, many of which were deemed prolonged and severe.

Many people with type 2 diabetes are only on a basal insulin and are more dependent on noninsulin therapies, and with the advent of additional noninsulin options, such as GLP-1 receptor agonists or SGLT2 inhibitors, their outcomes are improving. There is a community out there that feels that insulins are as good as they can be.

Nasal glucagon was noninferior to intramuscular glucagon for treating hypoglycemia in Japanese adults with type 1 or type 2 diabetes, according to findings published in Diabetes, Obesity and Metabolism.

More than 100,000 children and adults with type 1 diabetes using a hybrid closed-loop insulin delivery system maintained a blood glucose level in the recommended range 71.3% of the time and experienced an improvement in time in range when using the device in automode, according to a real-world analysis accepted for presentation at the Endocrine Society Annual Meeting.

Adults with type 2 diabetes are at greater risk for vision loss if they have smoked, had an episode of severe hypoglycemia or an elevated urinary albumin-to-creatinine ratio, according to findings published in the Journal of Diabetes and its Complications.

Continuous glucose monitors have revolutionized diabetes care since the first such device was approved by the FDA for personal use in 2005. Today, improvements in glucose sensor accuracy, smaller sensor size and ease of use have made it easier than ever for people with diabetes to monitor their blood glucose trends in real time — and Silicon Valley is taking notice.

Adults with type 1 diabetes who have diabetic peripheral neuropathy are more likely to experience severe hypoglycemia or diabetic ketoacidosis than their peers without peripheral neuropathy, according to findings published in Diabetes Care.